Weekly Intelligence · 5 articles

Vet Industry Intel: Jan 18 – Jan 24, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Regulatory & Policy (4) Products & Technology (1)

Regulatory & Policy

Jan 20, 2026 [9/10] Boehringer Ingelheim

FDA approves first drug to delay the onset of congestive heart failure in dogs

The FDA has approved the first drug by Boehringer Ingelheim to delay the onset of congestive heart failure in dogs.

FDA · Boehringer Ingelheim

Jan 19, 2026 [9/10] PR Newswire

FDA approves first drug to delay the onset of congestive heart failure in dogs

The U.S. Food and Drug Administration approved the first drug to delay the onset of congestive heart failure in dogs.

FDA

Jan 21, 2026 [8/10] DVM360

FDA grants full approval for canine idiopathic epilepsy medication

The FDA has granted full approval to a medication used to treat canine idiopathic epilepsy.

FDA · DVM360

Jan 22, 2026 [7/10] Bovine Veterinarian

nixiFLOR Injection Approved by the FDA for Bovine Respiratory Disease Treatment

The FDA has approved nixiFLOR Injection for the treatment of bovine respiratory disease, as reported by Bovine Veterinarian.

FDA · Bovine Veterinarian

Products & Technology

Jan 23, 2026 [7/10] DVM360

FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease

The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for the treatment of bovine respiratory disease.

FDA · DVM360